Stereotactic body radiotherapy for the pancreas: a critical review for the medical oncologist
about
Immune checkpoint blockade can synergize with radiation therapy, even in tumors resistant to checkpoint monotherapyOne- vs. Three-Fraction Pancreatic Stereotactic Body Radiation Therapy for Pancreatic Carcinoma: Single Institution Retrospective Review.The BET inhibitor I-BET762 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic effect of gemcitabine.Immune Checkpoint Inhibition for Pancreatic Ductal Adenocarcinoma: Current Limitations and Future Options
P2860
Stereotactic body radiotherapy for the pancreas: a critical review for the medical oncologist
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Stereotactic body radiotherapy ...... iew for the medical oncologist
@ast
Stereotactic body radiotherapy ...... iew for the medical oncologist
@en
Stereotactic body radiotherapy ...... iew for the medical oncologist
@nl
type
label
Stereotactic body radiotherapy ...... iew for the medical oncologist
@ast
Stereotactic body radiotherapy ...... iew for the medical oncologist
@en
Stereotactic body radiotherapy ...... iew for the medical oncologist
@nl
prefLabel
Stereotactic body radiotherapy ...... iew for the medical oncologist
@ast
Stereotactic body radiotherapy ...... iew for the medical oncologist
@en
Stereotactic body radiotherapy ...... iew for the medical oncologist
@nl
P2093
P2860
P356
P1476
Stereotactic body radiotherapy ...... iew for the medical oncologist
@en
P2093
Cheng-Chia Wu
David P Horowitz
Samuel K Kim
P2860
P304
P356
10.21037/JGO.2015.10.01
P407
P577
2016-06-01T00:00:00Z